DE69626987D1 - Pharmaceutische komposition - Google Patents

Pharmaceutische komposition

Info

Publication number: DE69626987D1
Authority: DE; Germany
Prior art keywords: pharmaceutical composition; wounds; mannose; healing; promoting
Prior art date: 1995-08-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69626987T

Other languages

English (en)

Other versions

DE69626987T2 (de

Inventor

William Ferguson

Sally Freeman

Glenys Moore

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Renovo Ltd

Original Assignee

Renovo Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-04

Filing date

1996-07-31

Publication date

2003-04-30

1996-07-31 Application filed by Renovo Ltd filed Critical Renovo Ltd

2003-04-30 Publication of DE69626987D1 publication Critical patent/DE69626987D1/de

2003-12-04 Application granted granted Critical

2003-12-04 Publication of DE69626987T2 publication Critical patent/DE69626987T2/de

2016-08-01 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE69626987T 1995-08-04 1996-07-31 Pharmaceutische komposition Expired - Lifetime DE69626987T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9516012.3A GB9516012D0 (en)	1995-08-04	1995-08-04	Pharmaceutical composition
PCT/GB1996/001840 WO1997005883A1 (en)	1995-08-04	1996-07-31	Pharmaceutical composition

Publications (2)

Publication Number	Publication Date
DE69626987D1 true DE69626987D1 (de)	2003-04-30
DE69626987T2 DE69626987T2 (de)	2003-12-04

Family

ID=10778773

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE69634905T Expired - Lifetime DE69634905T2 (de)	1995-08-04	1996-07-31	Phosphnatanaloge von Mannose-6-phosphate und deren Verwendung zur Förderung der Heilung von Wunden oder fibrotischen Störungen mit verminderter Narbenbildung
DE69626987T Expired - Lifetime DE69626987T2 (de)	1995-08-04	1996-07-31	Pharmaceutische komposition

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE69634905T Expired - Lifetime DE69634905T2 (de)	1995-08-04	1996-07-31	Phosphnatanaloge von Mannose-6-phosphate und deren Verwendung zur Förderung der Heilung von Wunden oder fibrotischen Störungen mit verminderter Narbenbildung

Country Status (13)

Country	Link
US (1)	US6140307A (de)
EP (2)	EP1291018B1 (de)
JP (2)	JPH11510179A (de)
AT (2)	ATE298579T1 (de)
AU (1)	AU719992B2 (de)
CA (1)	CA2229010C (de)
DE (2)	DE69634905T2 (de)
DK (2)	DK0841931T3 (de)
ES (2)	ES2195000T3 (de)
GB (1)	GB9516012D0 (de)
PT (2)	PT1291018E (de)
WO (1)	WO1997005883A1 (de)
ZA (1)	ZA966578B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2304047A (en) *	1995-08-09	1997-03-12	Univ Manchester	Pharmaceutical compositions containing cytokines
US6093388A (en) *	1996-08-12	2000-07-25	Btg International Limited	Mannose-6-phosphate composition and its use in treating fibrotic disorders
GB2316002B (en) *	1996-08-12	1998-09-23	British Tech Group	Mannose-6-phosphate composition and its use in treating fibrotic disorders
AUPQ872300A0 (en) *	2000-07-11	2000-08-03	Praxis Pharmaceuticals Pty Ltd	Compounds and methods
US7648966B2 (en) *	2003-05-20	2010-01-19	Pharmaxis Pty Limited	Mannose-6-phosphonate compounds for the treatment of inflammatory diseases
US20080057072A1 (en) *	2006-08-31	2008-03-06	Alcon Manufacturing, Ltd.	Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
WO2008144352A1 (en)	2007-05-17	2008-11-27	Sunny Biodiscovery, Inc.	Threitol phosphates, salts thereof and methods of use
GB0724231D0 (en) *	2007-12-12	2008-01-30	Renono Ltd	Methods for inhibiting scarring
GB0910078D0 (en)	2009-06-11	2009-07-22	Renovo Ltd	Uses of mannose-6-phosphate
GB0916334D0 (en)	2009-09-17	2009-10-28	Renovo Ltd	Inhibition of tendon adhesions
GB0916332D0 (en) *	2009-09-17	2009-10-28	Renovo Ltd	Medicaments
PL3833358T3 (pl)	2018-08-10	2024-03-04	New York University	Zastosowanie ligandów agonistycznych receptora igf-2 w leczeniu zespołu angelmana i autyzmu
CN112912102A (zh)	2018-08-10	2021-06-04	纽约大学	6-磷酸甘露糖及其修饰物用于增强记忆和减少记忆受损的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4703040A (en) *	1985-04-03	1987-10-27	Markov Angel K	Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
WO1990001938A1 (en) *	1988-08-19	1990-03-08	The Australian National University	Phosphosugar-based anti-inflammatory and/or immunosuppressive drugs
SE8904354D0 (sv) *	1989-12-21	1989-12-21	Matti Siren	A pharmaceutical composition
GB9205800D0 (en) *	1992-03-17	1992-04-29	British Tech Group	Treatment of fibrotic disorders
DK129293D0 (da) *	1993-11-16	1993-11-16	Carlsberg Lab	Carbonhydratholdige forbindelser, der kan binde sig til carbonhydratbindende receptorer

1995
- 1995-08-04 GB GBGB9516012.3A patent/GB9516012D0/en active Pending
1996
- 1996-07-31 ES ES96925883T patent/ES2195000T3/es not_active Expired - Lifetime
- 1996-07-31 DK DK96925883T patent/DK0841931T3/da active
- 1996-07-31 EP EP02079259A patent/EP1291018B1/de not_active Expired - Lifetime
- 1996-07-31 AT AT02079259T patent/ATE298579T1/de active
- 1996-07-31 US US09/011,138 patent/US6140307A/en not_active Expired - Fee Related
- 1996-07-31 CA CA002229010A patent/CA2229010C/en not_active Expired - Fee Related
- 1996-07-31 AU AU66248/96A patent/AU719992B2/en not_active Ceased
- 1996-07-31 PT PT02079259T patent/PT1291018E/pt unknown
- 1996-07-31 JP JP9508206A patent/JPH11510179A/ja active Pending
- 1996-07-31 DK DK02079259T patent/DK1291018T3/da active
- 1996-07-31 DE DE69634905T patent/DE69634905T2/de not_active Expired - Lifetime
- 1996-07-31 PT PT96925883T patent/PT841931E/pt unknown
- 1996-07-31 AT AT96925883T patent/ATE235245T1/de active
- 1996-07-31 ES ES02079259T patent/ES2243657T3/es not_active Expired - Lifetime
- 1996-07-31 WO PCT/GB1996/001840 patent/WO1997005883A1/en not_active Ceased
- 1996-07-31 DE DE69626987T patent/DE69626987T2/de not_active Expired - Lifetime
- 1996-07-31 EP EP96925883A patent/EP0841931B1/de not_active Expired - Lifetime
- 1996-08-02 ZA ZA9606578A patent/ZA966578B/xx unknown
2008
- 2008-04-02 JP JP2008095915A patent/JP2008239625A/ja active Pending

Also Published As

Publication number	Publication date
DE69634905D1 (de)	2005-08-04
JP2008239625A (ja)	2008-10-09
DE69634905T2 (de)	2006-04-27
ATE235245T1 (de)	2003-04-15
US6140307A (en)	2000-10-31
WO1997005883A1 (en)	1997-02-20
PT1291018E (pt)	2005-08-31
ZA966578B (en)	1998-02-02
JPH11510179A (ja)	1999-09-07
CA2229010C (en)	2009-06-02
AU6624896A (en)	1997-03-05
EP0841931B1 (de)	2003-03-26
DK0841931T3 (da)	2003-04-22
EP1291018B1 (de)	2005-06-29
GB9516012D0 (en)	1995-10-04
AU719992B2 (en)	2000-05-18
ES2243657T3 (es)	2005-12-01
EP1291018A1 (de)	2003-03-12
CA2229010A1 (en)	1997-02-20
HK1053264A1 (en)	2003-10-17
DK1291018T3 (da)	2005-09-12
EP0841931A1 (de)	1998-05-20
DE69626987T2 (de)	2003-12-04
PT841931E (pt)	2003-06-30
ES2195000T3 (es)	2003-12-01
ATE298579T1 (de)	2005-07-15

Publication	Publication Date	Title
GB9516287D0 (en)	1995-10-11	Pharmaceutical compositon
FR2626760B1 (fr)	1997-10-31	Endoscope, notamment pour la chirurgie endonasale
PT877716E (pt)	2005-02-28	Composicoes de vidro bioactivo para uso no tratamento de estruturas dentais
ATE235481T1 (de)	2003-04-15	Substituierte benzopyranderivate zur behandlung von entzündungen
IS5591A (is)	2000-08-18	Grunnmassaprótínsamsetningar til sáragræðslu
ATE235245T1 (de)	2003-04-15	Pharmaceutische komposition
ATE186220T1 (de)	1999-11-15	Wundheilung
ATE275966T1 (de)	2004-10-15	Activin stimulator enthaltende pharmazeutische zusammensetzung
ES2066096T3 (es)	1995-03-01	4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ATE231728T1 (de)	2003-02-15	Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
ITTO930024A0 (it)	1993-01-18	Composizione per accelerare la rimarginazione di ferite
GB9516073D0 (en)	1995-10-04	Pharmaceutical composition
AU1506692A (en)	1992-10-29	Pharmaceutical compositions
PT1115375E (pt)	2006-06-30	Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
PT661058E (pt)	2004-04-30	Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
BR9704964A (pt)	1998-10-27	Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais
BR9710992A (pt)	2000-10-24	Derivados anticovulsivos úteis no tratamento de psorìase
PT878195E (pt)	2002-09-30	Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
IT8919204A0 (it)	1989-01-26	Composizione per la prevenzione e la cura di parodontopatte.
KR970702034A (ko)	1997-05-13	과도한 산 분비와 관련된 경미한 위장관 질환의 치료를 위한 저용량 라니티딘 조성물(Low Dosage Ranitidine Compositions for the Treatment of Minor Gastrointestinal Disorders Associated with Excess Acid Secretion)
IT8419193A0 (it)	1984-01-17	Fortemente ioniche aventi azione compoisizioni farmaceutiche per la sulla mobilizzazione del calcio somministrazione orale di sostanze osseo.

Legal Events

Date	Code	Title	Description
2004-04-22	8364	No opposition during term of opposition